Hepatitis C cases are up 300%.
U.S. health officials said new cases of hepatitis C rose nearly 300 percent from 2010 to 2015, despite the availability of cures for the liver disease, fueled by a spike in the use of heroin and other injection drugs, according to a report released on Thursday.
In 2015, the national reported rate of hepatitis C was 0.8 per 100,000 persons with nearly 34,000 new infections, according to the report by the Centers for Disease Control and Prevention.
Access to clean syringes and a limit on Medicaid barriers to curative treatments for hepatitis C can reduce rates of death from the disease and transmission of the virus to others, the CDC said.
New treatments for hepatitis C with a cure rate of over 95 percent from Gilead Sciences , AbbVie and other drugmakers have the ability to virtually wipe out the disease, which can lead to cirrhosis, cancer, the need for a liver transplant or death.
Read full article: U.S. Hepatitis C Cases Soar on Spike in Heroin Use | Top News | US News
|Read Full Article: U.S. Hepatitis C Cases Soar on Spike in Heroin Use | Top News | US News|